Normocarb HF is the first solution approved for direct infusion into a CRRT circuit

Patients receiving hemofiltration require a solution that is simple, effective, and safe. Caregivers need to have absolute confidence in the product and its ability to work in any manner of administration.

Normocarb HF is a pharmaceutical-grade, clinically-tested, FDA approved, protocol-neutral hemofiltration solution for CRRT.

Normocarb HF is now widely available with bicarbonate concentrations of 25 mmol/L and 35 mmol/L. Normocarb HF is a hemofiltration or replacement solution for direct infusion into a CRRT circuit.

For patients receiving CRRT, the patient care solution is Normocarb HF.

FOR INTENSIVISTS

A safe and versatile solution that provides metabolic electrolyte control – regardless of protocol.

FOR PHARMACISTS

A practical and pharmaceutical-grade solution that reduces handling and eliminates the risk of error.

FOR NURSES

A simple and reliable solution that facilitates workflow and allows staff to focus on patient care.

FOR NEPHROLOGISTS

A lactate-free, protocol-neutral solution that maintains benefit over the long-term while limiting the risk of metabolic disturbances.